Casavola V, Turner R J, Guay-Broder C, Jacobson K A, Eidelman O, Pollard H B
Laboratory of Cell Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Am J Physiol. 1995 Jul;269(1 Pt 1):C226-33. doi: 10.1152/ajpcell.1995.269.1.C226.
The selective A1-adenosine-receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (CPX), has been reported to activate Cl- efflux from cystic fibrosis cells, such as pancreatic CFPAC-1 and lung IB3 cells bearing the cystic fibrosis transmembrane regulator(delta F508) mutation, but has little effect on the same process in cells repaired by transfection with wild-type cystic fibrosis transmembrane regulator (O. Eidelman, C. Guay-Broder, P. J. M. van Galen, K. A. Jacobson, C. Fox, R. J. Turner, Z. I. Cabantchik, and H. B. Pollard. Proc. Natl. Acad. Sci. USA 89: 5562-5566, 1992). We report here that CPX downregulates Na+/H+ exchange activity in CFPAC-1 cells but has a much smaller effect on cells repaired with the wild-type gene. CPX also mildly decreases resting intracellular pH. In CFPAC-1 cells, this downregulation is dependent on the presence of adenosine, since pretreatment of the cells with adenosine deaminase blocks the CPX effect. We also show that, by contrast, CPX action on these cells does not lead to alterations in intracellular free Ca2+ concentration. We conclude that CPX affects pH regulation in CFPAC-1 cells, probably by antagonizing the tonic action of endogenous adenosine.
据报道,选择性A1-腺苷受体拮抗剂8-环戊基-1,3-二丙基黄嘌呤(CPX)可激活囊性纤维化细胞(如携带囊性纤维化跨膜调节因子(delta F508)突变的胰腺CFPAC-1细胞和肺IB3细胞)中的氯离子外流,但对通过转染野生型囊性纤维化跨膜调节因子修复的细胞中的同一过程影响很小(O. 艾德尔曼、C. 盖伊-布罗德、P. J. M. 范加伦、K. A. 雅各布森、C. 福克斯、R. J. 特纳、Z. I. 卡班奇克和H. B. 波拉德。《美国国家科学院院刊》89: 5562 - 5566, 1992)。我们在此报告,CPX可下调CFPAC-1细胞中的Na+/H+交换活性,但对用野生型基因修复的细胞影响小得多。CPX还会轻微降低静息细胞内pH值。在CFPAC-1细胞中,这种下调依赖于腺苷的存在,因为用腺苷脱氨酶预处理细胞可阻断CPX的作用。我们还表明,相比之下,CPX对这些细胞的作用不会导致细胞内游离Ca2+浓度的改变。我们得出结论,CPX可能通过拮抗内源性腺苷的紧张性作用来影响CFPAC-1细胞中的pH调节。